Dr. Miguel Dario Cantu is a native of the Rio Grande Valley in South Texas. He graduated summa cum laude from the University of Texas Pan-American with a Bachelor of Science in Biology. He completed his medical training at the University of Texas Health Science Center at Houston’s McGovern Medical School followed by an Anatomic and Clinical Pathology Residency at New York Presbyterian – Weill Cornell in New York City where he served as Chief Resident of Anatomic Pathology. He pursued additional fellowship training in Hematopathology at New York Presbyterian—Weill Cornell followed by a Molecular Genetic Pathology fellowship at the University of Texas Southwestern. Dr. Cantu’s clinical research interests include the study of immunodeficiency-associated lymphoproliferative disorders and molecular pathogenesis of myeloid neoplasms. During his training, Dr. Cantu was a 2021 ASCP 40 Under 40 honoree and received the 2022 Pathologist-in-Training Award from the Society for Hematopathology and the 2022 Dr. Janet Caldwell Fellow Research Award for his work studying therapy-related myeloid neoplasms at UTSW. He holds multiple subspecialty board certifications from the American Board of Pathology that include Anatomic and Clinical Pathology, Hematopathology, and Molecular Genetic Pathology.